Endogena Therapeutics
San Francisco, US · Founded 2016 · Delaware corporation
Founders & leadership
Endogena Therapeutics was founded in 2016 by Matthias Steger.
MS
Matthias StegerFounder
EB
Elona BaumNamed on SEC filing
DZ
Daniel ZabrowskiNamed on SEC filing
DH
Dirk HarbeckeNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$15.3M disclosed across 2 rounds · 2020–2021
▶$7.3MraisedNov 2021 · 12 investors · OtherRule 506(b)
▶$7.3MraisedNov 2021 · 12 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Markus BertiniExecutive Officer
- Aaron WeaverDirector
- Daniel ZabrowskiDirector
- Elona BaumDirector
- Matthias StegerExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $7.3M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8MraisedJan 2021 · 13 investors · OtherRule 506(b)
▶$8MraisedJan 2021 · 13 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Matthias StegerExecutive Officer, Director
- Elona BaumDirector
- Daniel ZabrowskiDirector
- Dirk HarbeckeDirector
- Offering amount
- $8M
- Amount sold
- $8M
- Minimum investment
- $1
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Endogena Therapeutics?
- Endogena Therapeutics was founded by Matthias Steger in 2016.
- How much funding has Endogena Therapeutics raised?
- Endogena Therapeutics has disclosed $15.3M raised across 2 rounds.
- Where is Endogena Therapeutics headquartered?
- Endogena Therapeutics is headquartered in San Francisco, US.